Search
Fulcrum Therapeutics Inc
FULCAdd to Watchlist
3.765USD
+0.065+1.76%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
250.78MMarket Cap
LossP/E TTM
Fulcrum Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Fulcrum Therapeutics Inc is 7.02, ranking 273 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.23, which is -68.42% below the recent high of -1.02 and -38228.81% above the recent low of -1236.18.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
